This book does nothing less than lay out the state of
development of tomorrow 's cancer drugs, directed against growth
factors, growth factor receptors and intracellular signaling
molecules with kinase activities. The sequencing of the human
genome and insights into signaling pathways have contributed to the
understanding of cancer etiology and the development of new,
improved cancer drugs such as Herceptin and Glivec. The
deregulation of pathways due to mutated cancer genes provides the
conceptual basis for future progress. Will it be possible to derive
more efficient cancer drugs?
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!